Yung WK - Search Results

1

Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells.

Fu J, Koul D, Yao J, Wang S, Yuan Y, Colman H, Sulman EP, Lang FF, Yung WK. Fu J, et al. Among authors: yung wk. Cancer Res. 2013 May 15;73(10):3062-74. doi: 10.1158/0008-5472.CAN-12-2033. Epub 2013 Mar 14. Cancer Res. 2013. Retraction in: Cancer Res. 2014 Nov 15;74(22):6731-2. doi: 10.1158/0008-5472.CAN-14-2966 PMID: 23492364 Free PMC article. Retracted.

2

Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region.

Sheng X, Koul D, Liu JL, Liu TJ, Yung WK. Sheng X, et al. Among authors: yung wk. Biochem Biophys Res Commun. 2002 Mar 29;292(2):422-6. doi: 10.1006/bbrc.2002.6662. Biochem Biophys Res Commun. 2002. PMID: 11906179

3

VEGF(121), VEGF(165) overexpression enhances tumorigenicity in U251 MG but not in NG-1 glioma cells.

Ke LD, Shi YX, Yung WK. Ke LD, et al. Among authors: yung wk. Cancer Res. 2002 Mar 15;62(6):1854-61. Cancer Res. 2002. PMID: 11912165

4

Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.

Koul D, Jasser SA, Lu Y, Davies MA, Shen R, Shi Y, Mills GB, Yung WK. Koul D, et al. Among authors: yung wk. Oncogene. 2002 Apr 4;21(15):2357-64. doi: 10.1038/sj.onc.1205296. Oncogene. 2002. PMID: 11948419

5

MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.

Koul D, Shen R, Garyali A, Ke LD, Liu TJ, Yung WK. Koul D, et al. Among authors: yung wk. Int J Oncol. 2002 Sep;21(3):469-75. Int J Oncol. 2002. PMID: 12168088

6

Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategies.

Lang FF, Gilbert MR, Puduvalli VK, Weinberg J, Levin VA, Yung WK, Sawaya R, Fuller GN, Conrad CA. Lang FF, et al. Among authors: yung wk. Neuro Oncol. 2002 Oct;4(4):268-77. doi: 10.1093/neuonc/4.4.268. Neuro Oncol. 2002. PMID: 12356357 Free PMC article.

7

Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.

Fueyo J, Alemany R, Gomez-Manzano C, Fuller GN, Khan A, Conrad CA, Liu TJ, Jiang H, Lemoine MG, Suzuki K, Sawaya R, Curiel DT, Yung WK, Lang FF. Fueyo J, et al. Among authors: yung wk. J Natl Cancer Inst. 2003 May 7;95(9):652-60. doi: 10.1093/jnci/95.9.652. J Natl Cancer Inst. 2003. PMID: 12734316

8

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results.

Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S, Berger MS, McDermott MW, Kunwar SM, Junck LR, Chandler W, Zwiebel JA, Kaplan RS, Yung WK. Lang FF, et al. Among authors: yung wk. J Clin Oncol. 2003 Jul 1;21(13):2508-18. doi: 10.1200/JCO.2003.21.13.2508. J Clin Oncol. 2003. PMID: 12839017 Clinical Trial.

9

Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.

Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D, McMurray JS, Fang X, Yung WK, Siminovitch KA, Mills GB. Lu Y, et al. Among authors: yung wk. J Biol Chem. 2003 Oct 10;278(41):40057-66. doi: 10.1074/jbc.M303621200. Epub 2003 Jul 17. J Biol Chem. 2003. PMID: 12869565 Free article.

10

The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival.

Zhou YH, Tan F, Hess KR, Yung WK. Zhou YH, et al. Among authors: yung wk. Clin Cancer Res. 2003 Aug 15;9(9):3369-75. Clin Cancer Res. 2003. PMID: 12960124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters